It is also worth mentioning that MDA-MB468 is a breast cancer cell line that is triple negative (ER−/PR−/HER2-), which would typically be derived from an advanced, aggressive and metastasized clinical stage tumor. This evidence concerns the gene ERBB2 and breast cancer.